Hostname: page-component-77c89778f8-vpsfw Total loading time: 0 Render date: 2024-07-24T03:33:55.357Z Has data issue: false hasContentIssue false

A European psychopharmacology curriculum: The young psychiatrist's point of view

Published online by Cambridge University Press:  23 March 2020

S. Kasper
Affiliation:
Medical University of Vienna, Department of Psychiatry and Psychotherapy, Vienna, Austria

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

It goes without saying that psychopharmacologic treatment requires extensive knowledge of topics ranging from pharmacodynamics and efficacy, to pharmacokinetics, side-effects, and toxicity. Knowledge should be supplemented with experience regarding applicability in a clinical setting. It is well accepted that comprehensive psychopharmacologic education is essential to convey necessary knowledge and adequately prepare trainees for independent practice [1]. Currently, a psychopharmacologic curriculum, under the umbrella of the European Psychiatric Association, is in preparation in order to emphasize the importance of psychopharmacologic education in the context of psychiatric training and to foster standardization within the European Union. The aim of this presentation is to discuss psychopharmacologic education and prerequisites for an effective curriculum from the trainee's point of view. We will address challenges facing psychiatric trainees [2] and review existing curricula as well as literature in which they are evaluated. Based on evaluation of the model curriculum by the American Society of Clinical Psychopharmacology, one of the most broadly used psychopharmacologic curricula, it has been emphasized that an effective curriculum should be more than a list of topics. It should also convey pedagogic strategies with a focus on up-to-date technology, and provide a process through which teacher and trainee progress can be assessed [3,4]. Reflection on currently available curricula should aid in the development of an effective and timely EU-wide psychopharmacologic curriculum.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
W22
Copyright
Copyright © European Psychiatric Association 2016

References

Gardner, D.M. Competent psychopharmacology. Can J psychiatry 2014; 59(8): 406411CrossRefGoogle ScholarPubMed
Vazquez, G.H. The impact of psychopharmacology on contemporary clinical psychiatry. Can J psychiatry 2014; 59(8): 412416CrossRefGoogle ScholarPubMed
Glick, I.D., Zisook, S. The challenge of teaching psychopharmacology in the new millennium: the role of curricula. Acad Psychiatry 2005; 29(2): 134140CrossRefGoogle ScholarPubMed
Zisook, S., et al.Psychopharmacology curriculum field test. Acad Psychiatry 2009; 33(5): 358363CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.